Product Information

BUMETANIDE 1 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1585 per EA under NDC 68382052605. Its NADAC has been published 267 times since May 27, 2020.

The High Outlier badge above means this manufacturer's average price in the bumetanide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BUMETANIDE 1 MG TABLET

bumetanide
$0.1585per EA
High Outlier

Strength

1 mg/1

NDC

68382052605

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/18/2025

Active Ingredients

BUMETANIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202900

On Market Since

5/1/2018

Pharmacological Classes

Increased Diuresis at Loop of Henle
Loop Diuretic

Price Statistics

The NADAC for BUMETANIDE 1 MG TABLET has been published 267 times since May 27, 2020, and over the history we have for it it has declined 60.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1585 per EA
All-time high$0.3966 (Jun 10, 2020)
All-time low$0.1247 (Nov 20, 2024)
52-week high$0.1585
52-week low$0.1585
Median price$0.2169
Average price$0.2256
Largest weekly change+76.2% (Aug 21, 2024)
Weeks tracked267
Tracking sinceMay 27, 2020

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-17.8%

5Y

-35.3%

All

-60.0%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUMETANIDE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 1 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1585 per EA (NDC 68382052605), effective Jul 2, 2025.

How has the price of BUMETANIDE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUMETANIDE 1 MG TABLET has declined 60.0%. It has been tracked across 267 weekly CMS publications since May 27, 2020.

What are the highest and lowest recorded NADAC prices for BUMETANIDE 1 MG TABLET?

Since May 27, 2020, the NADAC for BUMETANIDE 1 MG TABLET has ranged from a low of $0.1247 (Nov 20, 2024) to a high of $0.3966 (Jun 10, 2020), with a median of $0.2169 per EA.

Are there cheaper alternatives to BUMETANIDE 1 MG TABLET?

Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUMETANIDE 1 MG TABLET, is $0.1109 per EA — about 30% below BUMETANIDE 1 MG TABLET.

Who manufactures BUMETANIDE 1 MG TABLET?

BUMETANIDE 1 MG TABLET (NDC 68382052605) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.